India’s largest pharma company has caught investors’ fancy and a lot of it is due to founder Dilip Shanghvi’s need to take a different path.
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
Limited time offer $125 $99 for 1 year
The food and grocery delivery company’s idea of providing prescription drugs in 10 minutes is facing resistance from traditional pharma players.
Specialty drugs are fast becoming a lucrative market globally. And India’s largest drugmaker has done well to make the most of this opportunity so far. But it’s too soon to rest easy.
To shed pounds fast, Indians are going to great lengths to secure weight-loss drugs from abroad. Soon, they may not have to look elsewhere as US drugmaker Eli Lilly gets early approvals in India for its new weight-loss drug.